Novo Nordisk
The companies hope to develop a PRS that can identify people at high risk for obesity before that phenotype emerges and to develop preventive therapeutic products.
Ovation.io Collecting WGS, Clinical Data From 8,500 Patients on GLP-1 Meds
The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.
The Together for CHANGE initiative aims to build the largest African ancestry genomic database while supporting the communities from which it is recruiting.
Meharry Medical College, Pharma Firms to Build Large-Scale African Ancestry Genomics Database
Regeneron, AstraZeneca, Novo Nordisk, and Roche will each commit $20 million to the project, which plans to sequence the genomes of up to 500,000 individuals.
The researchers used tissue and plasma proteomics to identify marker for detecting fibrosis, inflammation, and steatosis and for predicting liver-related events.